BIOCLINICA INC
Industrials · Services-Testing Laboratories · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | FY10 | FY09 | |
|---|---|---|---|---|
| Revenue | $98.3M | $84.0M | $75.2M | $72.7M |
| Operating income | $6.5M | $4.4M | $4.3M | $4.7M |
| Net income | $3.7M | $2.8M | $2.8M | $3.0M |
| Total assets | $101.0M | $90.4M | $80.0M | — |
| Total liabilities | $38.5M | $32.4M | $25.1M | — |
| Equity | $62.5M | $58.1M | $54.9M | $48.5M |
| EPS (diluted) | $0.23 | $0.17 | $0.17 | $0.20 |
| Shares out. | 15.6M | 15.6M | 15.6M | 15.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- 6.6%
- Net margin
- 3.8%
- Return on equity
- 6.0%
- Return on assets
- 3.7%
- Return on capital (ROCE)
- 9.0%
- Liabilities / assets
- 38.2%
- Debt / equity
- 0.62×
- Book value / share
- $3.99
- Revenue growth (YoY)
- 17.0%
- Net income growth (YoY)
- 33.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2012- Altman Z″ (distress)
- 3.50safe
- Accruals / assets
- −6.1%clean
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard notice · Unregistered equity sale · Change in control · Director / officer change · Amended charter or bylaws · Other material eventMar 14, 2013
- Results of operationsFeb 6, 2013
- Entered a material agreement · Modified shareholder rightsJan 30, 2013
- Results of operationsNov 8, 2012
- Results of operationsAug 8, 2012
- Shareholder vote · Other material eventMay 18, 2012
- Results of operationsMay 9, 2012
- Results of operationsFeb 9, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.